Literature DB >> 24846069

MicroRNA-mediated cancer metastasis regulation via heterotypic signals in the microenvironment.

Haizhong Ma, Chunli Liang, Guangxue Wang, Sujuan Jia, Qian Zhao, Zhendong Xiang, Yuan Li, William C Cho, Richard G Pestell, Li Liang, Zuoren Yu1.   

Abstract

MicroRNAs (miRNAs) are thought to regulate tumor progression and metastasis via direct interaction with target genes within cells. Emerging evidence has demonstrated the secretion of miRNAs into environment via cancer cell exosomes, called "exosomal shuttle small RNA". Microenvironmental miRNAs are important mediators of cell-to-cell communication, and they play important roles in regulating cancer metastasis. RNA analysis indicates enrichment of the miRNA population in cell-culturing medium. miRNA-conditioned medium is able to mediate the function of miRNAs in regulating cancer cell migration and invasion. Here we combine our recent work with literature discussing multiple mechanisms through which exosomal miRNAs regulate cancer cell migration, invasion and metastasis. We summarize a heterotypic signaling pathway by which miRNA regulates the cellular secretion and tumor microenvironment in control of breast cancer cell migration and invasion. In conclusion, exosomal miRNAs are able to regulate cancer metastasis via heterotypic signals in the microenvironment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24846069     DOI: 10.2174/1389201015666140516112042

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

1.  Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer.

Authors:  Chang Liu; Cathy Eng; Jianjun Shen; Yue Lu; Yoko Takata; Amir Mehdizadeh; George J Chang; Miguel A Rodriguez-Bigas; Yanan Li; Ping Chang; Yixiang Mao; Manal M Hassan; Fangyu Wang; Donghui Li
Journal:  Oncotarget       Date:  2016-11-15

2.  Identification of Nucleobindin-2 as a Potential Biomarker for Breast Cancer Metastasis Using iTRAQ-based Quantitative Proteomic Analysis.

Authors:  Liang Zeng; Jingmin Zhong; Guangchun He; Fangjun Li; Jing Li; Wen Zhou; Wenbin Liu; Yun Zhang; Sanqian Huang; Zhihong Liu; Xiyun Deng
Journal:  J Cancer       Date:  2017-09-02       Impact factor: 4.207

Review 3.  Critical analysis of the potential for microRNA biomarkers in breast cancer management.

Authors:  Carrie R Graveel; Heather M Calderone; Jennifer J Westerhuis; Mary E Winn; Lorenzo F Sempere
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-02-23

4.  Cancer stem cell property and gene signature in bone-metastatic Breast Cancer cells.

Authors:  An Luo; Yue Xu; Shujun Li; Jinxia Bao; Jinhui Lü; Nan Ding; Qian Zhao; Yuting Fu; Fei Liu; William C Cho; Xunbin Wei; Haiyun Wang; Zuoren Yu
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.